logo

For the Inventor, By the Inventor

Jiangsu, China

Crown Bioscience, Inc. (Taicang)


USPTO Granted Patents = 11

% Expired Patents = 18.2

Forward Citations = 6

Loading Chart...
Loading Chart...

28 inventors (with patents filed for the assignee):

goldMedal Henry Qixiang Li (6 out of 6 patents)

silverMedal Sheng Guo (5 out of 9 patents)

bronzeMedal Jie Cai (3 out of 3 patents)

4.  Binchen Mao (2 out of 2 patents)

5.  Yiyou Chen (1 out of 12 patents)

6.  Dawei Chen (1 out of 4 patents)

7.  Ziyong Sun (1 out of 3 patents)

8.  Wencui Ma (1 out of 3 patents)

9.  Hongli Ma (1 out of 3 patents)

10.  Daiwei Chen (1 out of 1 patent)

11.  Juan Zhang (1 out of 1 patent)

12.  Richard Peterson (1 out of 1 patent)

13.  Charles Van Jackson (1 out of 1 patent)

14.  Gao Sun (1 out of 1 patent)

15.  Guodong Zhang (1 out of 1 patent)


11 patents:

1. 11640849 - Methods for histological diagnosis and treatment of diseases (2023-05-02),
2. 11459618 - System and method for determining Cetuximab sensitivity on gastric cancer (2022-10-04),
3. 11339447 - System and method for determining Kareniticin sensitivity on cancer (2022-05-24),
4. 11136625 - Gene expression signatures predictive of subject response to a multi-kinase inhibitor and methods of using the same (2021-10-05),
5. 11020494 - Animal models for nonalcoholic fatty liver disease (2021-06-01),
6. 10683550 - HNF4G-RSPO2 fusion gene and use thereof in treatment of cancer (2020-06-16),
7. 10618962 - Anti-CTLA4 antibodies (2020-04-14),
8. 10501805 - Methods for determining responsiveness to MEK/ERK inhibitors (2019-12-10),
9. 10442862 - Use of EGFR biomarkers for the treatment of gastric cancer with anti-EGFR agents (2019-10-15),
10. 9921222 - Histological markers for identifying non-small cell lung carcinoma patients for treatment with an anti-EGFR drug (2018-03-20),
11. 9743646 - Method of establishing isogenic multi-xenograft model and the use thereof (2017-08-29),
Company Overview
Crown Bioscience, Inc. specializes in preclinical and translational research services, focusing on drug discovery and development. The company offers a comprehensive suite of services, including in vivo and in vitro models, biomarker analysis, and pharmacology studies, catering primarily to the pharmaceutical and biotechnology sectors. With a strong emphasis on oncology, metabolic diseases, and autoimmune disorders, Crown Bioscience operates from its headquarters in Jiangsu, China, contributing to advancements in personalized medicine and therapeutic innovations.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

11 Patents

#58 in Jiangsu

#2,552 in China

#51,761 in the World

Jiangsu, CN
Jiangsu, China

Crown Bioscience, Inc. (Taicang)

Forward Citations = 6

28 inventors:

goldMedal Henry Qixiang Li (6 out of 6 patents)

silverMedal Sheng Guo (5 out of 9 patents)

bronzeMedal Jie Cai (3 out of 3 patents)

4.  Binchen Mao (2 out of 2 patents)

5.  Yiyou Chen (1 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Crown Bioscience, Inc. (Taicang). Retrieved from https://idiyas.com/company/crown-bioscience-taicang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…